We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 60

FTC and Deceptive Advertising Claims Regarding Stem Cell Therapy
  • Baker McKenzie
  • USA
  • October 23 2018

On 18 October 2018, the Federal Trade Commission (FTC) announced that it had reached a settlement prohibiting two companies, Regenerative Medical


Life sciences: product regulation and liability in Thailand
  • Baker McKenzie
  • Thailand, Global
  • July 11 2018

A structured guide to product regulation and liability laws in Thailand


US FDA extends deadline for food industry to eliminate trans fats from food products
  • Baker McKenzie
  • USA
  • July 10 2018

On 21 May 2018, the U.S. Food and Drug Administration (“FDA”) rejected a food additive petition by the US Grocery Manufacturers Association (“GMA”)


Another Step Forward - FDA Issues Two Final Guidance Documents on Communicating Medical Product Information
  • Baker McKenzie
  • USA
  • June 21 2018

On 12 June 2018, the Food and Drug Administration (FDA) issued two final guidance documents providing feedback on acceptable means for drug and device


Local Cosmetic Manufacturers and Importers Required to Confirm Their Identity to the FDA within the Given Deadline
  • Baker McKenzie
  • USA
  • June 20 2018

Following our previous alert on the FDA’s announcement regarding the transfer of cosmetic data from Hello to Privus system, and the renewal of


US - APHIS to change policy for FDA approved human medical devices containing animal derived ingredients
  • Baker McKenzie
  • USA
  • May 25 2018

In a Stakeholder Importer Alert dated May 31, 2018, the Animal and Plant Health Inspection Service (APHIS), advised that in consultation with the Food


Pre-revenue Biotech Companies Can Apply For Listing In Hong Kong With Effect From 30 April 2018
  • Baker McKenzie
  • Hong Kong
  • April 26 2018

On 24 April 2018, The Stock Exchange of Hong Kong Limited (HKEx) published its Consultation Conclusions to HKEx's proposals to expand Hong Kong's


Procedures and strategies for pharmaceutical brands: United States
  • Baker McKenzie
  • USA
  • March 13 2018

Clearing and registering pharmaceutical trademarks in the United States are often more complex and challenging than in other countries. This is due in


February 2018 International Trade Compliance Update
  • Baker McKenzie
  • Global
  • February 6 2018

2018 Global Trade and Supply Chain Webinar Series “Continuing Challenge in Global Trade” registration and session details; WTO: trade policy review


US FDA Issues New Guidance for Digital Health
  • Baker McKenzie
  • USA
  • December 26 2017

With the increasing prevalence of digital health products and technology, the US Food and Drug Administration (US FDA) has launched several new pieces